Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-023767
Filing Date
2024-02-14
Accepted
2024-02-14 16:26:23
Documents
2
Group Members
JEREMY C. GREENREDCO II MASTER FUND, L.P

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245846d1_sc13ga.htm SC 13G/A 96966
2 EXHIBIT 99.1 tm245846d1_ex99-1.htm EX-99.1 7300
  Complete submission text file 0001104659-24-023767.txt   105978
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

EIN.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Subject) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91517 | Film No.: 24638939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)